Sentences with phrase «clinical studies which»

This is likely due to the clinical studies which have shown that this diet does not work as intended.

Now that we are done with the clinical studies which confirm that fish oil benefits hair, let us now have a look at some of the most common hair - related benefits of fish oil.

But when the researchers reviewed scientific literature on the bioactivity of chamomile, they discovered no human clinical studies which evaluated this calming effect.

But, in fact, there are no clinical studies which show that there is any difference between babies fed cow's milk and those fed formula.

Not exact matches

Novo is advancing its clinical study of its next big hope in treating obesity: semaglutide, a new drug in the so - called GLP - 1 category which imitates an intestinal hormone that stimulates the production of insulin.

Lilly faced a devastating clinical setback last year with a late - stage failure for its experimental Alzheimer's treatment, the studies for which cost the company hundreds of millions of dollars.

The striking example I focused on then was the cancer drug Avastin, developed by Genentech (now Roche)-- which, at the time, had been studied in at least 400 completed human clinical trials for various cancers.

WebMD cites a study led by Laura Berman, Ph.D., assistant clinical professor of psychiatry and ob - gyn at Northwestern University's Feinberg School of Medicine, which studied 2,000 couples.

Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three studies of the drug in multiple myeloma, a rare blood cancer, after a number of patient deaths.

But while thousands of clinical trials on immunotherapy drugs, of which many are predicted to fail, are springing up, the depth of information on neoantigen vaccines is much shallower: Just two studies on neoantigen vaccines for melanoma, recently profiled in Nature, were completed last year in Boston and Germany.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

Woo counters that Maastricht University in the Netherlands is currently conducting a clinical trial studying his company's supplements, which will publish at ClinicalTrials.gov.

First, the topline numbers: The study was an observational one rather than a randomized control trial, the latter of which is considered to be the «gold standard» of clinical studies.

A study published in The Journal of Clinical Endocrinology & Metabolism found that individuals who consume a calorie - restricted diet had lower levels of T3 thyroid hormone, which Healthline lists as a «hormone that helps maintain body temperature, among other functions.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

(Theranos criticized the study as «flawed and inaccurate» in a letter to The Journal of Clinical Investigation, which published the research.)

Another migraine drug, lasmiditan, which Lilly picked up with its 2017 acquisition of Colucid Pharmaceuticals, is in late - stage clinical studies.

Yet what attracted the most attention was a new deal with General Electric (NYSE: GE) under which GE's healthcare unit will help fund a clinical study of flurpiridaz F 18, which the companies believe could help improve diagnosis of coronary artery disease.

(This is one area in which the cultural narcissists studied in this book may differ from people with some forms of clinical narcissistic personality disorder.

Sad news from the halls of research today, in which a study published in the American Journal of Clinical Nutrition says that eating fried potatoes two or more times a week can double your risk of early death.

Several denominations have programs through which they encourage their clergymen to engage in continuing education, including clinical training and study in the area of counseling.

«The benefits of probiotics are strain specific, which means formulators need to look at the clinical studies supporting the exact probiotic strain used to determine what benefits to claim, and ensure inclusion rates through the end of shelf life to support these amounts,» Bush says.

They have conducted extensive clinical studies on the benefits of their exact collagen, which is superior to other collagen brands on the market due to their unique manufacturing process.

Using data from clinical food challenge studies, the VSEP has identified reference doses for the common food allergens at which 95 - 99 % of the allergic population are unlikely react (1,2).

A clinical study shows Optein's effectiveness in aiding muscle recovery after exercise, which proves its superior functionality in nutritional and protein drink powder mixes, sports beverages, smoothies, and protein, energy and meal replacement bars.

A series of studies printed in the American Journal of Clinical Nutrition found that adding a heaping teaspoon the brown powder to a starchy meal may help stabilize blood sugar and ward off insulin spikes, which allows your body to metabolize carbohydrates more efficiently.

Dr. Frederick Leickly, an allergist, writes in his blog about a study published in the Journal of Allergy and Clinical Immunology (JACI) which concluded that a sensitization to fenugreek was believed to have been caused by a peanut allergy in patients.

As Larry Leverenz, Ph.D, ATC, a co-author of the groundbreaking 2010 study (4) that was the first to identify such athletes noted, because such athletes have not suffered damage to areas of the brain associated with language and auditory processing, they are unlikely to exhibit clinical signs of head injury (such as headache or dizziness), or show impairment on sideline assessment for concussion, all of which test for verbal, not visual memory.

A US study, which was published in the Journal of Allergy and Clinical Immunology, found genetics and skin exposure to baby wipes, dust and food are all factors behind increasing levels of children with food allergies.

Finally, neurodevelopmental research has suggested that the factors in breast milk that may be responsible for the improved cognitive abilities of breastfed children may involve long chain polyunsaturated fatty acids and, particularly, docosahexaenoic acid (DHA), 10 with some clinical studies in which infant formula was supplemented with DHA suggesting possible improvements in visual acuity and cognitive ability in preterm infants given the DHA - supplemented formula.13

Summary: This study, published in Clinical Infectious Diseases in March 2010, examines the mechanism by which exclusive breastfeeding protects against...

Dr Paul Ramchandani — a researcher and clinical psychiatrist now based at the Academic Unit of Child and Adolescent Psychiatry, Department of Medicine, Imperial College London — led the study, which assessed father - infant interactions in the family home when the child was aged three months and compared them against the child's behaviour at the age of twelve months.

According to the recent study, which will be published next month in the print version of the American Journal of Clinical Nutrition, breastfeeding can cut the risk of breast cancer by up to 91 percent.

After much petitioning by the Center for Science in the Public Interest (CSPI), The Food and Drug Administration (FDA) has announced plans to form an advisory committee meeting which will review clinical studies conducted on common food dyes including Yellow 5 and Red 40 and the link connecting them to adverse behavior issues in children.

We conducted our study in conjunction with the clinical trials and epidemiology research unit, which is an independent organisation funded by the National Medical Research Council.

The study, which has just been published in the well known American Journal of Clinical Nutrition, is based on the Copenhagen General Population Sstudy, which has just been published in the well known American Journal of Clinical Nutrition, is based on the Copenhagen General Population StudyStudy.

«Our studies provide promising results in mice, which merit further investigation, such as adjusting the formulation, dose and delivery route of MAOA inhibitors, prior to ultimate clinical application.»

In the study, published in the Journal of Neuropsychiatry and Clinical Neurosciences, the researchers proposed the existence of a spectrum syndrome comprising a core anxiety disorder and four related domains, for which they have coined the term ALPIM:

The study, which is published in the journal Molecular Psychiatry, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain.

A clinical study will now be conducted of the new treatment, which has been developed in a collaboration between Chalmers University of Technology, Sahlgrenska University Hospital, the University of Gothenburg and Integrum.

In creating the new guidelines, which the organization revisits every couple of years, the WHO panel considered national guidelines and international guidelines, as well as relevant clinical studies, says Dr. Siobhan Crowley, who led the WHO's guideline revision process this year.

In a study published in Clinical Gastroenterology and Hepatology, Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually lead to some pancreatic cancers being detected earlier.

The Phase I clinical trial of OMP - 54F28 (FZD8 - Fc) is an open - label dose escalation study in patients with advanced solid tumors for which there was no remaining standard curative therapy.

Those studies, including their recent paper published in the medical journal Expert Review of Clinical Pharmacology, which demonstrated that the benefits of taking statins have been exaggerated and are misleading.

The drug is not approved for weight management, according to its manufacturer, Denmark - based Novo Nordisk, which sponsored this study, called the SCALE ™ (Satiety and Clinical Adiposity - Liraglutide Evidence in Nondiabetic and Diabetic Subjects) Obesity and Prediabetes trial.

In a trio of studies to be presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, investigators at Dana - Farber Cancer Institute will present the results of clinical trials showing that new drug combinations can significantly extend the time in which multiple myeloma is kept in check in patients with relapsed or treatment - resistant forms of the disease.

In clinical trials, some patients experienced reduced lung function, which Pfizer, on further study, found to be medically insignificant.

«This study raises important questions on the role of systemic inflammation, which is also elevated in depression, in driving a disease phenotype, which needs to be confirmed in clinical cohorts,» concluded Dr Barnabe.

Hee Yeon Kay, Derek Greene, Seungwoo Kang and Anastasia Kosenko with UCI contributed to study, which appears in the Journal of Clinical Investigation.

The REACT (Randomized Evaluation of an Algorithm for Crohn's Treatment) study, led by Robarts Clinical Trials at Western University (London, Canada) provides valuable new insights for community gastroenterologists which should benefit patients.